Gynica
PrivateLast Round
Seed
Jun 24, 2021
Est. Valuation
$7.75M
Total Funding Raised
$1.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gynica operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in June 2021.
Gynica is a clinical-stage biotech company that develops non-hormonal, cannabinoid-based therapeutic solutions for endometriosis and other gynecological conditions using its proprietary IntraVag drug delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gynica Comparables
Compare Gynica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Calla Lily Clinical Care | 81% | |
| FimmCyte | 76% | |
| Gesynta Pharma AB | 76% |
For institutional investors. Book with your work email.
Gynica Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 1306% MoM, reaching 1.7K.
- Nov 6, 2025
Monthly visitors grew 78% MoM, from 693 to 1.2K.
For institutional investors. Book with your work email.
Gynica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gynica's valuation, stock price, and market status.
Is Gynica a public or private company?
Gynica is a private company.
What is the current stock price of Gynica?
Gynica is a private company, so its shares have no public market price. Caplight tracks Gynica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gynica worth (valuation)?
Gynica's valuation is estimated at $7.8M based on funding round data.
Can I buy Gynica stock?
Gynica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gynica's last funding round?
Gynica's most recent funding round was Seed on June 24, 2021.
Who are the main investors in Gynica?
Investor information for Gynica is not publicly disclosed.
Will Gynica IPO soon?
No public IPO plans have been announced for Gynica.
How can I track Gynica secondary market activity?
Caplight tracks bids, offers, and trades in Gynica's shares on secondary markets.